Mauro Costa-Mattioli

Mauro Costa-Mattioli

Auto-generated profile, based on publicly available information

Mauro Costa-Mattioli

Altos Labs, Inc., Bay Area Institute, Redwood City, California, 94665, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2020 in Science
Verified
Journal Article
Closed access
PDF file
MCMauro Costa-Mattioli
Mauro Costa-Mattioli
PWPeter Walter
Peter Walter
Proteostasis dISRupted: Despite their importance, many crucial networks for protein quality control within cells diminish with age. The resulting loss of proteostasis, the process by which the health of a cell's proteins is monitored and maintained, is associated with a wide range of age-related human diseases. Costa-Mattioli and Walter review the integrated stress response (ISR), a central signaling network that responds to proteostasis defects by tuning protein synthesis. The ISR is activated in a wide range of pathological conditions, so a mechanistic understanding of its pathway may help in the development of therapeutic tools through which it can be modulated. Science , this issue p. eaat5314

1 June 2016 in Cell
Verified
Journal Article
Closed access
SBShelly A. Buffington
Shelly A. Buffington
GPGonzalo Viana Di Prisco
Gonzalo Viana Di Prisco
TAThomas A. Auchtung
Thomas A. Auchtung
NANadim J. Ajami
Nadim J. Ajami
JPJoseph F. Petrosino
Joseph F. Petrosino
MCMauro Costa-Mattioli
Mauro Costa-Mattioli

1 January 2009 in Neuron
Verified
Journal Article
Closed access
MCMauro Costa-Mattioli
Mauro Costa-Mattioli
WSWayne S. Sossin
Wayne S. Sossin
EKEric Klann
Eric Klann
NSNahum Sonenberg
Nahum Sonenberg

1 January 2019 in Neuron
Verified
Journal Article
Closed access
MSMartina Sgritta
Martina Sgritta
SDSean W. Dooling
Sean W. Dooling
SBShelly A. Buffington
Shelly A. Buffington
EMEric N. Momin
Eric N. Momin
MFMichael B. Francis
Michael B. Francis
MCMauro Costa-Mattioli
Mauro Costa-Mattioli

8 July 2014 in Annual Review of Neuroscience
Verified
Journal Article
Closed access
SBShelly A. Buffington
Shelly A. Buffington
WHWei Huang
Wei Huang
MCMauro Costa-Mattioli
Mauro Costa-Mattioli
Activity-dependent changes in the strength of synaptic connections are fundamental to the formation and maintenance of memory. The mechanisms underlying persistent changes in synaptic strength in the hippocampus, specifically long-term potentiation and depression, depend on new protein synthesis. Such changes are thought to be orchestrated by engaging the signaling pathways that regulate mRNA translation in neurons. In this review, we discuss the key regulatory pathways that govern translational control in response to synaptic activity and the mRNA populations that are specifically targeted by these pathways. The critical contribution of regulatory control over new protein synthesis to proper cognitive function is underscored by human disorders associated with either silencing or mutation of genes encoding proteins that directly regulate translation. In light of these clinical implications, we also consider the therapeutic potential of targeting dysregulated translational control to treat cognitive disorders of synaptic dysfunction.

3 March 2013 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
WHWei Huang
Wei Huang
PZPing Jun Zhu
Ping Jun Zhu
SZShixing Zhang
Shixing Zhang
HZHongyi Zhou
Hongyi Zhou
LSLoredana Stoica
Loredana Stoica
MCMauro Costa-Mattioli
Mauro Costa-Mattioli
Memory and associated plasticity mechanisms span different timescales, from fleeting to enduring. This study shows that, across species, mTORC2's control of actin dynamics is critical for long-term forms of memory and synaptic plasticity. A major goal of biomedical research is the identification of molecular and cellular mechanisms that underlie memory storage. Here we report a previously unknown signaling pathway that is necessary for the conversion from short- to long-term memory. The mammalian target of rapamycin (mTOR) complex 2 (mTORC2), which contains the regulatory protein Rictor (rapamycin-insensitive companion of mTOR), was discovered only recently and little is known about its function. We found that conditional deletion of Rictor in the postnatal murine forebrain greatly reduced mTORC2 activity and selectively impaired both long-term memory (LTM) and the late phase of hippocampal long-term potentiation (L-LTP). We also found a comparable impairment of LTM in dTORC2-deficient flies, highlighting the evolutionary conservation of this pathway. Actin polymerization was reduced in the hippocampus of mTORC2-deficient mice and its restoration rescued both L-LTP and LTM. Moreover, a compound that promoted mTORC2 activity converted early LTP into late LTP and enhanced LTM. Thus, mTORC2 could be a therapeutic target for the treatment of cognitive dysfunction.